Top Markets
Coin of the day
Tvardi Therapeutics, Inc. Tvardi Therapeutics, Inc.

Tvardi Therapeutics, Inc.

TVRD
Rank in Stocks #30249
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages... Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 1b/2 clinical development stage for fibrosis-driven diseases with an initial focus on idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC); and TTI-109, an oral, small molecule STAT3 inhibitor which is in Phase-1 clinical trial stage. Tvardi Therapeutics, Inc. was founded in 2017 and is based in Sugar Land, Texas.
Share Price
$1.88
Last synced: 2026-08-18
Market Cap
$17.59M
Change (1 day)
0.81%
Change (1 year)
-92.40%
Country
US
Trade Tvardi Therapeutics, Inc. (TVRD)

Category

Stock split history for Tvardi Therapeutics, Inc. (TVRD)
Tvardi Therapeutics, Inc. stock (symbol: TVRD) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 19, 2026.
One TVRD share bought prior to Aug 19, 2026 would equal to 0 TVRD shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR